Exicure Inc (FRA:2H0)
€ 1.48 0 (0%) Market Cap: 60.66 Mil Enterprise Value: 66.14 Mil PE Ratio: 0 PB Ratio: 41.48 GF Score: 31/100

Exicure Inc at Solebury Trout Virtual Management Access Event Transcript

Jan 11, 2021 / NTS GMT
Release Date Price: €264 (+12.82%)
Thomas Hoffman
Solebury Trout - Analyst

Welcome to 2021 Solebury Trout Access Management Event. Our next presentation comes from Exicure. Presenting for the company will be the CEO,

Our next presentation comes from Exicure. Presenting for the Company will be the CEO, David. Please go ahead.

David Giljohann
Exicure, Inc. - CEO, Interim Principal Financial Officer, Corporate Secretary, & Director

Thanks, Thomas. Hi, everybody, and thanks for joining today. My name is David Giljohann. I'm the CEO of Exicure. And on behalf of the entire Exicure team, I'm happy to welcome you here today to hear about our company and our promise for the future of medicine.

On this version of the deck labelled January 7, we will make forward-looking statements. And we are publicly listed companies, so I refer you to our SEC guidance.

So a little bit about Exicure. We have a platform technology called spherical nucleic acid or SNA that we'll talk about today, which leads to better uptake and greater stability of nucleic acid medicines. We've demonstrated

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot